Description
Using our intelligently designed and intuitive dataset, you can quickly understand how Crispr Therapeutics (CRSP) is lobbying the U.S. government, how much they’re spending on it, and most importantly – the bills and specific issues on which they lobby.
Gain an informational edge with our Lobbying Data Intelligence. Perform analysis by company, lobbyist, lobbying firm, government agency, or issue.
For lobbying firms: understand your competitors. Understand who is registering with who. Gain insight on quarterly reports and specific issues other firms are lobbying on.
Our lobbying data is collected and aggregated from the U.S. Senate Office of Public Records from 1999-present and is updated on a regular basis. We utilize advanced data science techniques to ensure accurate data points are collected and ingested, match similar entities across time, and tickerize publicly traded companies that lobby.
Our comprehensive and advanced lobbying database is completed with all the information you need, with more than 1.6 million lobbying contracts ready-for-analysis. We include detailed information on all aspects of federal lobbying, including the following fascinating attributes, among much more:
1. Clients: The publicly traded company, privately owned company, interest group, NGO, or state or local government that employs or retains a lobbyist or lobbying firm.
2. Registrants (Lobbying Firms): Either the name of the lobbying firm hired by the client, or the name of the client if the client employs in-house lobbyists.
3. Lobbyists: The names and past government work experience of the individual lobbyists working on a lobbying contract. 3. General Issues: The general issues for which clients lobby on (ex: ENV – Environment, TOB – Tobacco, FAM – Family Issues/Abortion).
4. Specific Issues: A long text description of the exact bills and specific issues for which clients lobby on.
5. Bills Lobbied On: The exact congressional bills and public/private laws lobbied on, parsed from lobbying report specific issues (ex: H.R. 2347, S. 1117, Tax Cuts and Jobs Act).
6. Agencies Lobbied: The names of one or more of 250+ government agencies lobbied on in the contract (ex: White House, FDA, DOD).
7. Foreign Entities: The names and origin countries of entities affiliated with the client (ex: BNP Paribas: France).
Gain access to our highly unique and actionable U.S. lobbying database. Further information on LobbyingData.com and our alternative datasets and database can be found on our website, or by contacting [email protected].
Frequently Asked Questions
What is Crispr Therapeutics (CRSP) lobbying for?
Summary of the lobbying data:
– Crispr Therapeutics hired two lobbying firms: Todd Strategy Group and Crispr Therapeutics, Inc.
– They lobbied on general issues such as medical/disease research/clinical labs, pharmacy, Medicare/Medicaid, and health issues.
– They also lobbied on specific issues such as reimbursement and FDA regulatory pathways for cell and gene therapies, access and reimbursement for cell and gene therapies, generic drugs, and FDA approval policies for cell and gene therapies.
– They lobbied the Senate, Department of Health & Human Services (HHS), Centers For Medicare and Medicaid Services (CMS), and the House of Representatives.
One could infer that Crispr Therapeutics is lobbying on these issues to further their interests in the cell and gene therapy market. They are likely advocating for favorable regulations and reimbursements for these therapies, which can be expensive to develop and market. The specific mention of H.R.4128 – VALID Act and H.R.6000 – Cures 2.0 suggests that they are also trying to influence legislation related to the approval and coverage of these therapies. Crispr Therapeutics is a biotechnology company that develops gene editing technology, including for use in developing cell and gene therapies, so lobbying on these issues aligns with their business goals.
